Hematology/Oncology Clinics of North America PDF

Journal Spotlight: Hematology/Oncology Clinics of North America

Hematology/Oncology Clinics of North America is a trusted resource for healthcare professionals seeking the latest insights and updates in the field of hematology and oncology. Published six times a year, this journal covers a wide range of topics related to patient management, treatment advances, and emerging trends in the discipline. Here are some key features of this valuable resource:

• Comprehensive Coverage: Each issue of Hematology/Oncology Clinics of North America is dedicated to a specific topic within hematology and oncology. These topics encompass a broad spectrum, including hemostasis and thrombosis, molecular and cellular aspects of hematology, coagulation disorders, and various types of cancers such as bone, gastrointestinal, head and neck, lymphomas, neuroendocrine, breast, renal cell, melanoma, and more. This focused approach allows readers to delve deeply into specific areas of interest.
• Expert Guest Editors: Each issue is curated and directed by an experienced guest editor who is a subject matter expert in the chosen topic. This ensures that the content is both authoritative and up to date.
• Timely Updates: With six issues published annually, Hematology/Oncology Clinics of North America provides regular and timely updates on the latest developments in the field. Healthcare professionals can rely on this journal to stay current with advances in patient management and treatment options.
• Clinical Relevance: The journal emphasizes the clinical relevance of the topics covered. It offers practical insights that can be directly applied to patient care, making it a valuable resource for oncologists, hematologists, nurses, and other healthcare providers.
• Print and Online Access: Subscribers can access the journal in both print and digital formats, providing flexibility and convenience in how they choose to engage with the content.

Hematology/Oncology Clinics of North America plays a crucial role in advancing the practice of hematology and oncology by offering a platform for in-depth exploration of critical topics. It supports healthcare professionals in making informed decisions about patient care and treatment strategies.

• Alexandra P. Wolanskyj-Spinner MD – Mayo Clinic Alix School of Medicine, Department of Internal Medicine, Hematology Division, Core Consultative Hematology Group, Mayo Clinic College of Medicine and Science, Rochester, MN, USA
• Ronald S. Go MD – Department of Internal Medicine, Hematology Division, Chair Core Consultative Hematology Group, Mayo Clinic College of Medicine and Science, Rochester, MN, USA

• Benjamin L. Schlechter MD – Gastrointestinal Cancer Center, Harvard Medical School, Dana Farber Cancer Institute, Boston, MA, USA
• Kimmie Ng MD, MPH – Gastrointestinal Cancer Center, Harvard Medical School, Dana Farber Cancer Institute, Boston, MA, USA

• Nirali N. Shah MD, MHSc – Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD, USA
• Sung-Yun Pai MD – Immune Deficiency Cellular Therapy Program, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD, USA

• Douglas A. Rubinson MD, PhD – Harvard Medical School, Gastrointestinal Cancer Center, Dana-Farber Cancer Institute, Boston, MA, USA
• Matthew B. Yurgelun MD – Harvard Medical School, Gastrointestinal Cancer Center, Dana-Farber Cancer Institute, Boston, MA, USA

• Sophie Lanzkron MD, MHS – Department of Medicine, Johns Hopkins School of Medicine, Baltimore, MD, USA
• Jane Little MD – Department of Medicine and UNC Blood Research Center, University of North Carolina School of Medicine, Chapel Hill, NC, USA

• Victoria Forbes MD, MS – University of Connecticut Health Center, Carole and Ray Neag Comprehensive Cancer Center, Farmington, CT, USA
• Dafina Ademi Islami MD, PhD – Oncology Clinic, University Clinical Center of Kosovo, Prishtina, Kosovo Ilir Hoxha MD, MPH – The Dartmouth Institute for Health Policy and Clinical Practice, Geisel School of Medicine at Dartmouth, Lebanon, NH, USA

• Kevin M. Elias MD – New England Trophoblastic Disease Center, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology and Reproductive Biology, Brigham and Women’s Hospital, Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA, USA
• Antonio Braga MD, PhD – Fluminense Federal University, Rio de Janeiro, RJ, Brazil, Department of Obstetrics and Gynecology, Rio de Janeiro Trophoblastic Disease Center, Maternity School of Rio de Janeiro, Federal University, Rua Laranjeiras, Laranjeiras, Rio de Janeiro, Rio de Janeiro, Brazil, Vassouras University, Vassouras, RJ, Brazil
• Neil S. Horowitz MD – New England Trophoblastic Disease Center, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology and Reproductive Biology
• Ross S. Berkowitz MD – New England Trophoblastic Disease Center, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology and Reproductive Biology